INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 45h ago
House PTR5h ago
SEC 13F5h ago
Robinhood Chain5h ago

Results

71,174 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
0
CR
Corbin Charles R. Jr.See Remarks
HGVHilton Grand Vacations Inc.
Option exercise · 10b5-1 plan
M—
6,365 sh
Nov 4, 2026
Page 44 of 1780
← PrevNext →
Nov 6, 2026
traded Nov 4, 2026
+2d
SEC Form 4

Evidence

0
SJ
Sinclair JackDirector, Chief Executive Officer
SFMSprouts Farmers Market, Inc.
Option exercise · 10b5-1 plan
M—
10.8K sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

0
SJ
Sinclair JackDirector, Chief Executive Officer
SFMSprouts Farmers Market, Inc.
Option exercise · 10b5-1 plan
M—
10.8K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

0
SJ
Sinclair JackDirector, Chief Executive Officer
SFMSprouts Farmers Market, Inc.
Option exercise · 10b5-1 plan
M$178K
10.8K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M—
11.9K sh
Nov 6, 2026Nov 6, 2026
traded Nov 6, 2026
+0dSEC Form 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M—
11.9K sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M—
11.9K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M$144K
11.9K sh
Nov 6, 2026Nov 6, 2026
traded Nov 6, 2026
+0dSEC Form 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M$144K
11.9K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

0
VJ
Vassil JonathanChief Revenue Officer
TOSTToast, Inc.
Option exercise · 10b5-1 plan
M$16K
900 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

0
VJ
Vassil JonathanChief Revenue Officer
TOSTToast, Inc.
Option exercise · 10b5-1 plan
M—
900 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

0
VJ
Vassil JonathanChief Revenue Officer
TOSTToast, Inc.
Option exercise · 10b5-1 plan
M—
3,700 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

0
SS
Skates SpenserDirector, CEO and President, 10% Owner
AMPLAmplitude, Inc.
Derivative conversion · 10b5-1 plan
C—
901 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

0
SS
Skates SpenserDirector, CEO and President, 10% Owner
AMPLAmplitude, Inc.
Derivative conversion · 10b5-1 plan
C—
901 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

0
PK
Patel Sanj KDirector, CHAIRMAN & CEO
KNSAKiniksa Pharmaceuticals International, plc
Option exercise · 10b5-1 plan
M—
145.8K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

0
SC
Seidman Becker CarynDirector, Chief Executive Officer, 10% Owner
YOUClear Secure, Inc.
Disposition to issuer · 10b5-1 plan
D—
176.1K sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

0
SC
Seidman Becker CarynDirector, Chief Executive Officer, 10% Owner
YOUClear Secure, Inc.
Grant or award · 10b5-1 plan
A—
176.1K sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

0
SC
Seidman Becker CarynDirector, Chief Executive Officer, 10% Owner
YOUClear Secure, Inc.
Option exercise · 10b5-1 plan
M—
176.1K sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

0
PJ
Peters William JDirector, CFO, EVP & TREASURER
AMPHAmphastar Pharmaceuticals, Inc.
Option exercise · 10b5-1 plan
M—
11.0K sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

0
FD
Fairbank Richard DDirector, Chairman and CEO
COFCAPITAL ONE FINANCIAL CORP
Option exercise · 10b5-1 plan
M—
40.7K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

0
SS
Skates SpenserDirector, CEO and President, 10% Owner
AMPLAmplitude, Inc.
Derivative conversion · 10b5-1 plan
C—
61 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

0
DP
Duffy Sean P.Director, Chief Executive Officer
OMDAOmada Health, Inc.
Option exercise · 10b5-1 plan
M$75K
12.9K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$14K
500 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

0
VJ
Vassil JonathanChief Revenue Officer
TOSTToast, Inc.
Option exercise · 10b5-1 plan
M$64K
3,700 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

0
KA
King Ryan ADirector, Co-Founder
CHYMChime Financial, Inc.
Derivative conversion · 10b5-1 plan
C—
63.4K sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

0
CR
Corbin Charles R. Jr.See Remarks
HGVHilton Grand Vacations Inc.
Option exercise · 10b5-1 plan
M—
31.4K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M$144K
11.9K sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

0
DP
DIRK VAN DE PUTDirector, Chief Executive Officer
MDLZMondelez International, Inc.
Option exercise · 10b5-1 plan
M—
20.9K sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

0
SJ
Sinclair JackDirector, Chief Executive Officer
SFMSprouts Farmers Market, Inc.
Option exercise · 10b5-1 plan
M$178K
10.8K sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

0
AI
Alclear Investments, LLCDirector, 10% Owner, See Remarks
YOUClear Secure, Inc.
Option exercise · 10b5-1 plan
M—
176.1K sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

0
DP
DIRK VAN DE PUTDirector, Chief Executive Officer
MDLZMondelez International, Inc.
Option exercise · 10b5-1 plan
M—
108.4K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

0
ZM
Zerbe Robert L MdDirector
VCELVericel Corp
Option exercise · 10b5-1 plan
M—
2,500 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

0
ZM
Zerbe Robert L MdDirector
VCELVericel Corp
Option exercise · 10b5-1 plan
M$6,525
500 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

0
ZM
Zerbe Robert L MdDirector
VCELVericel Corp
Option exercise · 10b5-1 plan
M$33K
2,500 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

0
ZM
Zerbe Robert L MdDirector
VCELVericel Corp
Option exercise · 10b5-1 plan
M—
500 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

0
AI
Alclear Investments, LLCDirector, 10% Owner, See Remarks
YOUClear Secure, Inc.
Disposition to issuer · 10b5-1 plan
D—
176.1K sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

0
MJ
Michaelson JenniferChief Scientific Officer
CGEMCullinan Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$16K
3,805 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

0
SJ
Siegal JonathanPrincipal Accounting Officer
VCELVericel Corp
Option exercise · 10b5-1 plan
M—
1,500 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

0
AL
Azar Samak LChief Legal Officer
GFSGLOBALFOUNDRIES Inc.
Open-market sale · 10b5-1 plan
SELL$13K
335 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

0
OP
O'Day Daniel PatrickDirector, Chairman & CEO
GILDGILEAD SCIENCES, INC.
Option exercise · 10b5-1 plan
M—
9,810 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence